The intended audience for this educational initiative is physicians, physician assistants, and nurse practitioners, clinicians who are often involved in the diagnosis and initial assessment of skin cancer.
At the conclusion of an activity, participants should be able to:
Evaluate current and emerging clinical trial data for gene expression profiling in melanoma diagnosis
Identify high‐risk patients with melanoma based on the latest staging systems and gene expression profiling
Discuss the utility of emerging gene expression profiling assays for risk stratification of cSCC
Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other relevant professional organizations, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of an accredited continuing education program provided by the Potomac Center for Medical Education are required to disclose to PCME all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by PCME in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by PCME to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships have been mitigated by PCME.
Faculty, Authors, and Content Developers
The faculty, authors and content developers reported the following relevant financial relationships with ineligible companies:
Sylvana Brickley, DNP, FNP-BC, DCNP
Sylvana Brickley, DNP, FNP-BC, DCNP: has no relevant financial relationships.
Aaron S. Farberg, MD, FAAD
Dermatology Research Institute
Baylor Scott & White Health System
Aaron S. Farberg, MD, FAAD: Consulting Fee: Amgen, Castle Biosciences, Galderma, Incyte, Novartis, Pfizer, Sun Pharmaceuticals, Ortho-Dermatologics
Cynthia Griffith, MPAS, PA-C
Physician Assistant University of Texas Southwestern Medical Center
Department of Dermatology
Editor in Chief Journal of Dermatology Physician Assistants
Cynthia Griffith, MPAS, PA-C: has no relevant financial relationships
Sherrif Ibrahim, MD, PhD
Associate Professor of Dermatology
University of Rochester Medical Center
Rochester, New York
Sherrif F. Ibrahim, MD, PhD: Consulting Fee: Castle, Galderma, Regeneron; Contracted Research: Biofrontera, Castle, Galderma, Regeneron, Replimune; Honoraria: Castle, Genentech, Regeneron; Speakers' Bureau: Castle, Genentech, Regeneron
The contents of some CME activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test, with a score of 70% or better, and evaluation. The estimated time for completion of this activity is 1 hour. To receive their certificates, participants must demonstrate mastery of the presented material via the post-test. Participant is allowed to take the post-test multiple times.
PHYSICIAN ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
PHYSICIAN CREDIT DESIGNATION STATEMENT
The Potomac Center for Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit or the evaluation, please email email@example.com.
AMERICAN ASSOCIATION OF NURSE PRACTIONERS (AANP) CREDIT DESIGNATION STATEMENT
This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 22095768. This activity was planned in accordance with AANP Accreditation Standards and Policies.
AMERICAN ASSOCIATION OF PHYSICIAN ASSISSTANTS (AAPA) CREDIT DESIGNATION STATEMENT
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 9/30/2022 to 9/30/2023 . PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-208016.